Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021
https://doi.org/10.14341/DM12759
Abstract
BACKGROUND. One of the priority directions in the development of the health care system is to reduce the medical and social damage caused by the increase in the prevalence of diabetes mellitus (DM). From this point of view, the development of a diabetes register is very important as the main information and analytical platform for clinical and epidemiological monitoring of diabetes in the Russian Federation (RF).
AIMS. The aim of our study was to analyze a dynamic (2016–2020) of the epidemiological characteristics of diabetes mellitus in the Russian Federation (prevalence, morbidity, mortality), the prevalence of complications, the level of HbA1c and the dynamics of the structure of glucose-lowering therapy (GLT) according to the Federal Diabetes Register (FDR).
MATERIALS AND METHODs. The database of FRD (http://diaregistry.ru) 84 regions of the RF. The data are presented in dynamics 2016→2020.
RESULTS. The total number of DM patients in the RF as of 01.01.2021 was 4,799,552 (3.23% of the population), including: Type 1 (T1) — 5.5% (265.4 ths) , T2 — 92.5% (4.43 million), other DM types — 2.0% (99.3 ths). The dynamics of prevalence was 168.7→180.9/100 ths people with T1, and 2709 → 3022/100 ths people with T2; morbidity in T1 10.5→7.7/100 ths population, in T2 219.6→154.2/100 ths population. Age and sex characteristics: the proportion of men in T1 — 54%, in T2 — 30%; the max proportion of patients with T1 at the age of 30–39 years, T2 65–69 years. Mortality: T1 3.0 → 2.7/100 ths population, T2 87.7→93.9/100 ths of the population, the main cause of death was cardiovascular: in T1 38,1% cases, in T2 — 52,0%. Life expectancy (average age of death of patients): T1 was 53.2years, the dynamics in males 50.7 → 50.5years, females 58.7→55.2years; in T2 — 73.5 years, males 70.2→70.1years, females 75.7→75.4 years. The dynamic of DM duration until the death: in T1 17.4→19.0 years; in T2 11→11.4 years. The incidence of diabetic complications in T1 and T2 patients: neuropathy 43.3% and 24.4%, nephropathy (CKD) 25.9% and 18.4%, retinopathy 31.7% and 13.5%, respectively. The proportion of patients with HbA1c <7%: in T1 32.3%→36.9%, in T2 51.9%→52.1%, with HbA1c ≥ 9.0% in T1 23.1%→18.7% , in T2 8.9%→8.0%. The structure GLT in T2 patients: glucose lowering medications (GLM) — 76.2% (monotherapy — 44.1%; combination of 2 GLM — 28.9%, 3 GLM — 3.2%), insulin therapy in 18,8%, without drug therapy in 4.9%.
CONCLUSIONS. The performed analysis demonstrates the importance of dynamic assessment of epidemiological characteristics and monitoring of clinical data on patients with diabetes through a registry for assessing the quality of diabetes care and the prospects for its development.
About the Authors
I. I. DedovRussian Federation
Ivan I. Dedov, MD, PhD, Professor
Moscow
eLibrary SPIN: 5873-2280
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
M. V. Shestakova
Russian Federation
Marina V. Shestakova, MD, PhD, Professor
Moscow
eLibrary SPIN: 7584-7015
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
O. K. Vikulova
Russian Federation
Olga K. Vikulova, MD, PhD, associate professor
11 Dm.Ulyanova street, 117036 Moscow
eLibrary SPIN: 9790-2665
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
A. V. Zheleznyakova
Russian Federation
Anna V. Zheleznyakova, MD, PhD
Moscow
eLibrary SPIN: 8102-1779
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
M. А. Isakov
Russian Federation
Mikhail А. Isakov, PhD in Biology
Moscow
eLibrary SPIN: 5870-8933
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
References
1. IDF Diabetes Atlas, 9th edition. Brussels: International Diabetes Federation; 2019; Available from: https://www.diabetesatlas.org/en/
2. Dedov I.I., Shestakova M.V., Vikulova O.K., и др. Atlas of Diabetes Register in Russian Federation, status 2018 // Diabetes mellitus. – 2019. – Т. 22. – №2S. – C. 4-61(In Russ.) doi: 10.14341/DM12208
3. Dedov II, Shestakova MV, Vikulova OK. National register of diabetes mellitus in Russian Federation: status on 2014. Diabetes mellitus. 2015;18(3):5-23. (In Russ.) doi: 10.14341/DM201535-22
4. Shestakova MV, Vikulova OK, Isakov MA, Dedov II. Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the Russian Diabetes Registry. Problems of Endocrinology. 2020;66(1):35-46. (In Russ.) doi: https://doi.org/10.14341/probl12458
5. gks.ru. Russian Federal State Statistics Service. Доступно по: www.gks.ru.
6. Dedov II, Shestakova MV, Vikulova OK. Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry. Diabetes mellitus. 2017;20(1):13-41. (In Russ.) doi: 10.14341/DM8664
7. Dedov II, Shestakova MV, Vikulova OK, et.al. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of hypoglycaemic therapy according to the Federal Diabetes Register, status 2017. Diabetes Mellitus. 2018;21(3):144-159 doi: 10.14341/DM9686
8. Письмо Минздравсоцразвития РФ от 26.04.2011 N 14-9/10/2-4150 Доступно по: http://base.garant.ru/4192897/
9. Данные Росстата, ДЕМОГРАФИЧЕСКИЙ ЕЖЕГОДНИК РОССИИ. 2019, https://gks.ru/folder/210/document/13207
10. Zheleznyakova A.V., Vikulova O.K., Serkov A.A. et al. Dynamic monitoring of cardiovascular diseases in patients with diabetes mellitus according to mobile medical center (Diamodule) in the regions of Russia. Consilium Medicum. 2020; 22 (10): 39–44. (In Russ.) DOI: 10.26442/20751753.2020.10.200323
11. Shestakova MV, Vikulova OK, Zheleznyakova AV, et al. Diabetes epidemiology in Russia: what has changed over the decade? Therapeutic Archive. 2019;91(10):4–13. (In Russ.) doi: https://doi.org/10.26442/00403660.2019.10.000364
12. Dedov I.I., Shestakova M.V., Mayorov A.Y., и др. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition // Diabetes mellitus. – 2019. – Т. 22. – №1S1. – C. 1-144. (In Russ.) doi: 10.14341/DM221S1
13. Vikulova OK, Zheleznyakova AV, Isakov MA et al. Dynamic analysis of glycaemic control parameters in the regions of Russia according to the data of the mobile medical centre (Diamodul) and Federal Diabetes Register. Diabetes Mellitus. 2020;23(2):104-112. (In Russ.) doi: https: doi.org/10.14341/DM12327
14. Dedov I.I., Shestakova M.V., Mayorov A.Y. et al. Diabetes mellitus type 1 in adults. Diabetes mellitus. 2020;23(1S):42-114. (In Russ.) https://doi.org/10.14341/DM12505
15. Dedov I.I., Shestakova M.V., Mayorov A.Y., et al. Diabetes mellitus type 2 in adults. Diabetes mellitus. 2020;23(2S):4-102. (In Russ.) https://doi.org/10.14341/DM12507
16. Mayorov AY, Vikulova OK, Zheleznyakova AV et al. Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013–2016). Diabetes Mellitus. 2018;21(6):444-454 doi: 10.14341/DM10028
17. Dedov II, Shestakova MV, Peterkova VA et al. Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013–2016. Diabetes mellitus. 2017;20(6):392-402. . (In Russ.) doi: 10.14341/DM9460
Review
For citations:
Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.А. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204-221. (In Russ.) https://doi.org/10.14341/DM12759

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).